Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Understanding ISO 11607-2:2016 – Validation Requirements for Packaging of Terminally Sterilized Medical Devices
A Comprehensive Guide to CAN/CSA-ISO 11607-2:16 Implementation and Compliance
Packaging for terminally sterilized medical devices must ensure that the sterile barrier system remains intact until the point of use. ISO 11607-2:2016 (adopted in Canada as CAN/CSA-ISO 11607-2:16) specifies the validation requirements for the processes used to form, seal, and assemble sterile packaging systems. This article provides a technical overview of the standard’s scope, key requirements, implementation considerations, and compliance notes.
Scope and General Framework
ISO 11607-2:2016 is part of the two-part ISO 11607 series. While Part 1 establishes requirements for materials, sterile barrier systems, and packaging system design, Part 2 focuses exclusively on process validation. The standard applies to industrial and healthcare facilities that perform forming, sealing, or assembly of packaging for terminally sterilized medical devices.
The validation framework is based on the process‑lifecycle model: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Additional emphasis is placed on change control, re‑validation, and process monitoring after commercialization.
Technical Requirements and Validation Pathways
Process Qualification
IQ confirms that equipment and ancillary systems are installed according to specifications. OQ establishes process parameter limits (e.g., temperature, pressure, dwell time) by challenging worst‑case conditions. PQ demonstrates that the process consistently yields packaging that meets the defined specifications under actual production conditions.
Performance Testing
All validated processes must undergo performance tests defined in ISO 11607‑1. These include:
| Test Type | Purpose | Typical Parameters |
|---|---|---|
| Seal Strength | Measure force required to separate sealed areas | Minimum and maximum peel force (N/15 mm) |
| Seal Integrity | Detect leaks or channels in the seal | Dye penetration, bubble emission, vacuum leak test |
| Microbial Barrier | Verify that the sterile barrier resists microbial ingress | Bacterial aerosol challenge (ASTM F1608, ISO 19272) |
| Aging (Real‑time & Accelerated) | Ensure package stability over intended shelf life | Temperature, humidity, time duration |
| Package Integrity during Distr. | Simulate shipping, handling, and storage stresses | Drop, vibration, compression (ASTM D4169, ISTA protocols) |
Validation must include sampling plans with statistical confidence levels (usually 95% confidence, 90% reliability for attribute data).
Tip: When designing OQ studies, always include the extremes of the process window (e.g., minimum and maximum sealing temperature) to demonstrate robustness. Document all process parameter ranges clearly in the validation protocol.
Implementation Highlights for Manufacturers
Successful implementation of ISO 11607‑2 requires a cross‑functional effort involving quality, engineering, and production teams. Key highlights include:
- Change Management: Any change to equipment, materials, or processes must trigger a re‑evaluation as defined in the standard’s change control clause (Clause 6).
- Process Monitoring: After initial validation, routine monitoring (e.g., seal strength testing at defined intervals) must be performed. The standard does not prescribe fixed frequencies, but they should be risk‑based and justified.
- Personnel Competence: Operators and technicians must be trained on validated limits and on how to react when process parameters drift.
- Documentation: All validation plans, protocols, reports, and change requests must be retained. Traceability of packaging lots to validation runs is critical during audits.
Success Factor: Manufacturers who integrate the validation principles of ISO 11607‑2 into their daily production workflows (rather than treating validation as a one‑time event) often see fewer non‑conformances and smoother regulatory submissions.
Caution: A common pitfall during regulatory audits is incomplete OQ testing—especially failure to justify the worst‑case conditions. Ensure that your protocols clearly describe how worst‑case parameters were selected and that all relevant seal geometries (e.g., seal width, shape) are covered.
Compliance and Auditing Notes
Compliance with ISO 11607‑2 is not optional for medical device manufacturers seeking CE marking under the EU MDR or premarket approval in other jurisdictions. Auditors from notified bodies, FDA, and Health Canada will review:
- Validation master plan (or equivalent document)
- IQ/OQ/PQ protocols and reports for each packaging line
- Raw data supporting statistical sampling and acceptance criteria
- Records of deviations encountered during validation and their resolution
- Evidence of ongoing process monitoring and re‑validation activities
Because CAN/CSA-ISO 11607-2:16 is a national adoption identical to the international version, the same validation expectations apply in Canada. Manufacturers exporting to multiple regions should align their internal standards with the latest edition of the ISO text to avoid duplication of effort.
Audit Red Flag: Lack of a formal change control system that extends to packaging processes is a frequent observation. Even minor alterations (e.g., changing a sealing bar coating) can impact seal integrity and must be assessed per the standard’s re‑validation criteria.
Frequently Asked Questions
Q: Does ISO 11607‑2 require re‑validation after every routine maintenance activity?
A: Not necessarily. The standard distinguishes between “routine” maintenance (e.g., replacement of worn seal bars with identical parts) and “non‑routine” changes that alter the process. For routine maintenance, the impact should be assessed; re‑validation is required only if the change affects the critical process parameters or the output’s ability to meet specifications.
A: Not necessarily. The standard distinguishes between “routine” maintenance (e.g., replacement of worn seal bars with identical parts) and “non‑routine” changes that alter the process. For routine maintenance, the impact should be assessed; re‑validation is required only if the change affects the critical process parameters or the output’s ability to meet specifications.
Q: Can we perform one validation for multiple packaging machines of the same model?
A: Grouping (or “bracketing”) is allowed if the machines are demonstrated to be identical in design, operation, and control. Each machine must still be individually IQ‑qualified, but OQ/PQ can cover a representative sample if supported by a clear rationale and risk assessment.
A: Grouping (or “bracketing”) is allowed if the machines are demonstrated to be identical in design, operation, and control. Each machine must still be individually IQ‑qualified, but OQ/PQ can cover a representative sample if supported by a clear rationale and risk assessment.
Q: How often should we re‑validate a stable, well‑performing sealing process?
A: The standard does not prescribe a fixed re‑validation frequency. Many manufacturers use a periodic review (e.g., annually or biennially) combined with continuous monitoring. If monitoring data shows consistent results, a full re‑validation may be deferred; however, any significant drift in performance or a major process change will initiate a new validation.
A: The standard does not prescribe a fixed re‑validation frequency. Many manufacturers use a periodic review (e.g., annually or biennially) combined with continuous monitoring. If monitoring data shows consistent results, a full re‑validation may be deferred; however, any significant drift in performance or a major process change will initiate a new validation.
Q: Is ISO 11607‑2 applicable to non‑industrial settings, such as hospital sterile processing departments?
A: Yes. The standard applies to any facility performing forming, sealing, or assembly of sterile barrier systems. Hospitals must comply with the same principles, though the scale and documentation may be adapted to the context. Many national guidelines (e.g., HTM 01‑05 in the UK, CSA Z314 series in Canada) reference ISO 11607‑2 for healthcare settings.
A: Yes. The standard applies to any facility performing forming, sealing, or assembly of sterile barrier systems. Hospitals must comply with the same principles, though the scale and documentation may be adapted to the context. Many national guidelines (e.g., HTM 01‑05 in the UK, CSA Z314 series in Canada) reference ISO 11607‑2 for healthcare settings.
Article prepared for informational purposes. For specific compliance interpretations, consult the official text of ISO 11607‑2:2016 and CAN/CSA-ISO 11607‑2:16. © 2026